Aaron Brinkworth
Net worth: 12 692 $ as of 2026-09-29
Net worth: 12 692 $ as of 2026-09-29
Mr. Aaron Brinkworth is an Independent Non-Executive Director at Proteomics International Laboratories Ltd. and a Chairman at Resonance Health Ltd. He is on the Board of Directors at Proteomics International Laboratories Ltd. and Lixa Pty Ltd. Mr. Brinkworth was previously employed as an Executive Director-Global Patient Solutions by Gilead Sciences, Inc. He received his undergraduate degree from the University of Edith Cowan.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-06-29 | 135,135 ( 0.08% ) | 12 692 $ | 2026-09-29 |
| Companies | Position | Start |
|---|---|---|
| RESONANCE HEALTH LIMITED | Chairman | 2025-11-12 |
| PROTEOMICS INTERNATIONAL LABORATORIES LTD | Director/Board Member | 2024-11-07 |
Lixa Pty Ltd.
Lixa Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antimicrobial resistance | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2020-07-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Resonance Health Ltd.
Resonance Health Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare company, which involves in the development and commercialization of technologies & services for radiological images | Health Services |
University of Edith Cowan
University of Edith Cowan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd. Medical/Nursing ServicesHealth Services Provides biological research and drug discovery services | Health Services |
Lixa Pty Ltd.
Lixa Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antimicrobial resistance | Health Technology |
Select your edition
All financial news and data tailored to specific country editions